Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • masterpiece
    Member
    • Mar 2009
    • 40

    #1

    to complete or not to complete

    Hi guys,

    I want to get opinion from you all. For some of us might think completing a genome assembly (in this case sample from microbe) might be easy. But for some of us with limited of experience and fund, this practice could be difficult and time consuming.

    For example, fishing-out genes for drug target, is it important to get genome complete assembled or is it enough by working on partially complete genome assembly. When i said partial complete, means its on the scaffold stage.

    I hope someone can enlighten me, on what situation complete genome should be a choice, and on what situation working with partially complete is enough.

    thanks in advance

    -kamal
  • chkuo
    Member
    • May 2010
    • 11

    #2
    This is a rather complex question. One simple way to look at it is that a partial genome can tells you some of the genes that are present in the genome, however, if you want to know which genes are truly absent then you'd need a complete genome.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...